Trials / No Longer Available
No Longer AvailableNCT03196934
Expanded Use of Cannabidiol Oral Solution
A Multicenter, Open-label, Flexible Dose Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029 or Part A of INS011-15-054
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- MultiCare Health System Research Institute · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- —
Summary
To allow subjects who have completed Insys 030 extension study to continue to take Cannabidiol oral solution.
Detailed description
To allow subjects who have completed Insys 030 extension study (A multicenter, open-label, flexible dose study to assess the long-term safety of pharmaceutical Cannabidiol Oral Solution as an adjunctive treatment for pediatric subjects with a treatment-resistant seizure disorder who complete INS011-14-029 or Part A of INS011-15-054) to continue to take Cannabidiol oral solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol oral solution | Cannabidiol; Pharmacological class of drug |
Timeline
- First posted
- 2017-06-23
- Last updated
- 2024-02-02
Source: ClinicalTrials.gov record NCT03196934. Inclusion in this directory is not an endorsement.